Leigh Vosseller - Nov 3, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP & CHIEF FINANCIAL OFFICER
Signature
s/ David B. Berger, Attorney-in-Fact for Leigh A. Vosseller
Stock symbol
TNDM
Transactions as of
Nov 3, 2021
Transactions value $
-$1,023,305
Form type
4
Date filed
11/5/2021, 04:45 PM
Previous filing
Oct 14, 2021
Next filing
Dec 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $189K +10K +162.73% $18.86 16.1K Nov 3, 2021 Direct F1
transaction TNDM Common Stock Sale -$1.4M -10K -61.94% $140.05 6.15K Nov 3, 2021 Direct F2, F3
holding TNDM Common Stock 145 Nov 3, 2021 Leigh A. Vosseller Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Stock Option Options Exercise $189K +10K +193.8% $18.86 15.2K Nov 3, 2021 Common Stock 10K $18.86 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon exercise of a stock option award.
F2 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2021.
F3 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $140.00 to $140.18. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F4 The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee.
F5 The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F6 The expiration date for these options is 10 years from the date of grant.